ClinConnect ClinConnect Logo
Search / Trial NCT04146714

Substance Use Screening to Encourage Behavior Change Among Young People in Primary Care

Launched by PROF. DAGMAR M. HALLER · Oct 30, 2019

Trial Information

Current as of June 26, 2025

Not yet recruiting

Keywords

ClinConnect Summary

This clinical trial is studying whether filling out a short questionnaire about substance use while waiting to see a doctor can help reduce excessive drinking and drug use among young people aged 14 to 24. When young patients come to a primary care clinic, they will randomly get either a questionnaire about their substance use or one about physical activity. Later, the researchers will check back with them at 3, 6, and 12 months to see if their substance use has changed. The goal is to find out if those who completed the substance use questionnaire are less likely to engage in excessive substance use compared to those who filled out the physical activity questionnaire.

To participate in this study, young people must be between 14 and 24 years old and visiting the primary care clinic for any reason. However, those with immediate health issues, serious mental health conditions, or who are not patients at the clinic cannot take part. Participants can expect to fill out a questionnaire during their visit and receive follow-up surveys later. This trial aims to improve health behaviors among young people, and it is an exciting opportunity to contribute to important research in a supportive environment.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • - Patients aged 14 to 24 years consulting at the participating primary care practice for any motive.
  • Exclusion Criteria:
  • Acute illness requiring immediate attention of the physician
  • Severe mental health conditions requiring treatment in a specialized setting
  • Young person not consulting as a patient at the practice (e.g. accompanying friend or partner)
  • Inability to read the trial information in French or to provide independent consent.

About Prof. Dagmar M. Haller

Prof. Dagmar M. Haller is a distinguished clinical trial sponsor known for her extensive expertise in medical research and a commitment to advancing healthcare through innovative clinical studies. With a robust background in clinical pharmacology and patient-centered research, she leads initiatives aimed at evaluating novel therapies and interventions. Prof. Haller is dedicated to fostering collaboration among multidisciplinary teams to ensure the highest standards of scientific rigor and ethical conduct in clinical trials. Her work not only contributes to the body of medical knowledge but also strives to improve patient outcomes and quality of life.

Locations

Geneva, , Switzerland

Geneva, , Switzerland

Patients applied

0 patients applied

Trial Officials

Dagmar M Haller, MD,PhD

Principal Investigator

Faculty of Medicine, University of Geneva

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials